TP53 and cancer: The difficulty to link p53 mutation status to clinical outcome and cancer treatment can be explained by the fact that mutations of the p53 gene do not necessarily result in inactivation of p53 transcriptional activity (Kato et al, 2003; Iacopetta et al, 2006; Petitjean et al, 2007b).